BiotechTube
Home/Rejuvenate Bio/Deborah Ascheim, M.D.
DA

Deborah Ascheim, M.D.

Chief Medical Officer

Rejuvenate Bio

Therapeutic Areas

Age-related DiseasesMetabolic DiseaseCardiovascular DiseaseRenal Disease

Rejuvenate Bio Pipeline

DrugIndicationPhase
Canine Gene Therapy for MVDCanine Mitral Valve DiseasePre-clinical/Development
Human Combination Gene TherapyMultiple Age-Related Diseases (e.g., metabolic, cardiovascular)Pre-clinical

Leadership Team at Rejuvenate Bio

GC
George Church, Ph.D.
Co-Founder and SAB Chair
DO
Daniel Oliver, MBA
CEO, Co-Founder
ND
Noah Davidsohn, Ph.D.
CSO, Co-Founder
View full Rejuvenate Bio profile